On December 11, 2020, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the first vaccine against COVID-19, the Pfizer-BioNTech COVID-19 vaccine.1 This announcement was quickly followed by EUAs of the Moderna COVID-19 vaccine on December 18, 2020, and the Johnson & Johnson COVID-19 vaccine on February 27, 2021.2,3 Most mass…
Psoriasis is a chronic inflammatory disorder that affects approximately 3.2% of the US population.1 Although psoriasis was long considered to affect only the skin and joints, its underlying cause involves helper T-cell type 1 (TH1) immune dysregulation that can affect other organ systems.2 Individuals with psoriasis are at increased risk for cardiovascular disease, hypertension, and…
By identifying hardships and fears, dispelling myths and misunderstandings, and finding individualized treatment options, we can help patients relieve some of the burdens of chronic disease and improve longevity and quality of life.
Approximately 70% to 80% of women in their reproductive years develop fibroids, which can cause heavy menstrual bleeding, anemia, and poor quality of life.
Shared decision-making is important when determining treatment options for people with epilepsy.
Adherence to follow-up care in HIV treatment is important for improving health outcomes for people living with HIV and decreasing the number of new HIV infections.
Clinicians need to discuss the types of atrial fibrillation (AF), assessment tools used to designate stroke risk, and best treatment options to prevent stroke when the diagnosis of AF is made.
Dysphagia affects more than half of older patients and often necessitates a change in how oral medications are delivered.
